These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18572030)

  • 1. Intravascular ultrasound assessment of expansion of the sirolimus-eluting (cypher select) and paclitaxel-eluting (Taxus Express-2) stent in patients with diabetes mellitus.
    Jensen LO; Maeng M; Mintz GS; Christiansen EH; Hansen KN; Galloe A; Kelbaek H; Hansen HS; Joergensen E; Lassen JF; Thuesen L; Thayssen P
    Am J Cardiol; 2008 Jul; 102(1):19-26. PubMed ID: 18572030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: the Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial.
    Jensen LO; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Galloe A; Kelbaek H; Lassen JF; Thuesen L
    Eur Heart J; 2008 Nov; 29(22):2733-41. PubMed ID: 18832385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial intravascular ultrasound analysis of peri-stent remodeling and proximal and distal edge effects after sirolimus-eluting or paclitaxel-eluting stent implantation in patients with diabetes mellitus.
    Jensen LO; Maeng M; Mintz GS; Christiansen EH; Hansen KN; Galloe A; Kelbaek H; Lassen JF; Thuesen L; Thayssen P
    Am J Cardiol; 2009 Apr; 103(8):1083-8. PubMed ID: 19361594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the sirolimus-eluting versus paclitaxel-eluting coronary stent in patients with diabetes mellitus: the diabetes and drug-eluting stent (DiabeDES) randomized angiography trial.
    Maeng M; Jensen LO; Galloe AM; Thayssen P; Christiansen EH; Hansen KN; Helqvist S; Botker HE; Lassen JF; Thuesen L
    Am J Cardiol; 2009 Feb; 103(3):345-9. PubMed ID: 19166687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Procedural success and 10-month outcome between Cypher and TAXUS drug-eluting stents for the treatment of in-stent restenosis].
    Chen JL; Yang YJ; Qiao SB; Yao M; Qin XW; Xu B; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr; 35(4):305-7. PubMed ID: 17711652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An intravascular ultrasound study of Cypher, Taxus, and endeavor stents on relation between neointimal proliferation and residual plaque burden.
    Lee CH; Zhang J; Kailasam A; Tai BC; Ye F; Low AF; Hou X; Hay ET; Teo SG; Lim YT; Chen S; Tan HC
    J Interv Cardiol; 2008 Dec; 21(6):519-27. PubMed ID: 18973509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year results of the CRISTAL Trial, a randomized comparison of cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents.
    Chevalier B; Moulichon R; Teiger E; Brunel P; Metzger JP; Pansieri M; Carrie D; Stoll HP; Wittebols K; Spaulding C; Fajadet J;
    J Interv Cardiol; 2012 Dec; 25(6):586-95. PubMed ID: 22994863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].
    Silber S; Herdeg C
    Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravascular ultrasound assessment of drug-eluting stent expansion.
    de Ribamar Costa J; Mintz GS; Carlier SG; Fujii K; Sano K; Kimura M; Tanaka K; Costa RA; Lui J; Na Y; Castellanos C; Biro S; Moussa I; Stone GW; Moses JW; Leon MB
    Am Heart J; 2007 Feb; 153(2):297-303. PubMed ID: 17239693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms and Patterns of Intravascular Ultrasound In-Stent Restenosis Among Bare Metal Stents and First- and Second-Generation Drug-Eluting Stents.
    Goto K; Zhao Z; Matsumura M; Dohi T; Kobayashi N; Kirtane AJ; Rabbani LE; Collins MB; Parikh MA; Kodali SK; Leon MB; Moses JW; Mintz GS; Maehara A
    Am J Cardiol; 2015 Nov; 116(9):1351-7. PubMed ID: 26341188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the incidence of late stent thrombosis after implantation of different drug-eluting stents in the real world coronary heart disease patients: three-year follow-up results.
    Chen JL; Gao LJ; Yang YJ; Li JJ; Qiao SB; Xu B; Huang JH; Yao M; Qin XW; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Gao RL
    Chin Med J (Engl); 2010 Apr; 123(7):778-81. PubMed ID: 20497663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of plaque prolapse after drug-eluting stent implantation in diabetic patients: a three-dimensional volumetric intravascular ultrasound outcome study.
    Futamatsu H; Sabaté M; Angiolillo DJ; Jimenez-Quevedo P; Corros C; Morikawa-Futamatsu K; Alfonso F; Jiang J; Cervinka P; Hernandez-Antolin R; Macaya C; Bass TA; Costa MA
    J Am Coll Cardiol; 2006 Sep; 48(6):1139-45. PubMed ID: 16978996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation.
    Hong MK; Mintz GS; Lee CW; Park DW; Choi BR; Park KH; Kim YH; Cheong SS; Song JK; Kim JJ; Park SW; Park SJ
    Eur Heart J; 2006 Jun; 27(11):1305-10. PubMed ID: 16682378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of short- and long-term outcomes between Cypher and TAXUS drug-eluting stents for in-stent restenosis.
    Chen JL; Yang YJ; Qiao SB; Yao M; Qin XW; Xu B; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL
    Chin Med Sci J; 2007 Mar; 22(1):5-8. PubMed ID: 17441309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of short- and mid-term outcomes between CYPHER and TAXUS stents in patients with complex lesions of the coronary arteries.
    Chen JL; Gao RL; Yang YJ; Qiao SB; Qin XW; Yao M; Liu HB; Xu B; Wu YJ; Yuan JQ; Chen J; Dai J; You SJ; Ma WH
    Chin Med J (Engl); 2006 Jan; 119(1):21-5. PubMed ID: 16454977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and clinical impact of fracture of drug-eluting stents widely used in current clinical practice: comparison with initial platform of sirolimus-eluting stent.
    Park MW; Chang K; Her SH; Lee JM; Choi YS; Kim DB; Kim PJ; Cho JS; Choi MS; Baek JY; Park CS; Yoon SG; Chung WS; Seung KB
    J Cardiol; 2012 Sep; 60(3):215-21. PubMed ID: 22890068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials.
    Weissman NJ; Ellis SG; Grube E; Dawkins KD; Greenberg JD; Mann T; Cannon LA; Cambier PA; Fernandez S; Mintz GS; Mandinov L; Koglin J; Stone GW
    Eur Heart J; 2007 Jul; 28(13):1574-82. PubMed ID: 17540849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial.
    Hermiller JB; Raizner A; Cannon L; Gurbel PA; Kutcher MA; Wong SC; Russell ME; Ellis SG; Mehran R; Stone GW;
    J Am Coll Cardiol; 2005 Apr; 45(8):1172-9. PubMed ID: 15837245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target lesion revascularisation in patients treated with a sirolimus-eluting or paclitaxel-eluting stent.
    Maeng M; Okkels Jensen L; Rasmussen K; Flensted Lassen J; Romer Krusell L; Thayssen P; Thuesen L
    Heart; 2007 Jun; 93(6):694-7. PubMed ID: 17194711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.